Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSENTAN for Connective tissue disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 62 adverse event reports in the FDA FAERS database where BOSENTAN was used for Connective tissue disorder.

Most Reported Side Effects for BOSENTAN

Side Effect Reports % Deaths Hosp.
Dyspnoea 2,492 12.7% 501 1,640
Death 2,388 12.2% 2,384 689
Pneumonia 1,064 5.4% 264 946
Fatigue 1,025 5.2% 116 449
Headache 962 4.9% 94 467
Hospitalisation 915 4.7% 105 913
Malaise 894 4.6% 130 445
Diarrhoea 840 4.3% 132 484
Product dose omission issue 798 4.1% 18 174
Pulmonary arterial hypertension 778 4.0% 358 506
Nausea 765 3.9% 98 428
Condition aggravated 739 3.8% 239 464
Dizziness 721 3.7% 95 376
Cough 705 3.6% 100 400
Off label use 659 3.4% 100 272

Other Indications for BOSENTAN

Pulmonary arterial hypertension (12,387) Product used for unknown indication (3,679) Pulmonary hypertension (2,337) Scleroderma associated digital ulcer (246) Skin ulcer (211) Systemic scleroderma (120) Heart disease congenital (65) Cor pulmonale chronic (60) Raynaud's phenomenon (59) Scleroderma (52)

Other Drugs Used for Connective tissue disorder

AMBRISENTAN (857) RITUXIMAB (134) TREPROSTINIL (109) MACITENTAN (107) SILDENAFIL (104) MYCOPHENOLATE MOFETIL (86) HYDROXYCHLOROQUINE (74) ETANERCEPT (73) METHOTREXATE (59) SELEXIPAG (52)

Related Pages

BOSENTAN Full Profile All Connective tissue disorder Drugs BOSENTAN Demographics BOSENTAN Timeline